SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
---|---|---|---|---|---|---|---|---|---|
24-Sep-24 6:56 PM View: | Shafmaster Madge K. Director | Promis Neurosciences Inc. (PMN) | 24-Sep-24 | Purchase | 70,000 | $1.30 | $91,028.00 | 51% 138.33K to 208.33K | |
24-Sep-24 6:56 PM View: | Shafmaster Madge K. Director | Promis Neurosciences Inc. (PMN) | 23-Sep-24 | Purchase | 70,000 | $1.28 | $89,656.00 | 102% 68.33K to 138.33K | |
24-Sep-24 6:56 PM View: | Shafmaster Madge K. Director | Promis Neurosciences Inc. (PMN) | 20-Sep-24 | Private Purchase | 60,000 | $1.25 | $75,066.00 | 720% 8.33K to 68.33K | |
18-Sep-24 4:15 PM View: | Gordon Michael S 10% Owner | Promis Neurosciences Inc. (PMN) | 17-Sep-24 | Purchase | 16,292 | $1.40 | $22,808.80 | < 1% 2.2M to 2.22M | |
18-Sep-24 4:15 PM View: | Gordon Michael S 10% Owner | Promis Neurosciences Inc. (PMN) | 16-Sep-24 | Private Purchase | 76,931 | $1.22 | $94,071.20 | 4% 2.12M to 2.2M | |
16-Aug-24 7:38 AM View: | Kirwin Patrick D. Director | Promis Neurosciences Inc. (PMN) | 14-Aug-24 | Private Purchase | 10,000 | $1.25 | $12,492.00 | 11% 89.1K to 99.1K | |
25-Aug-23 4:15 PM View: | Milbury Max A. Principal Accounting Officer | Promis Neurosciences Inc. (PMN) | 23-Aug-23 | Grant | 13,297 | -- | -- | 782% 1.7K to 15.0K | |
25-Aug-23 4:19 PM View: | Farfel Gail M Chief Executive Officer Director | Promis Neurosciences Inc. (PMN) | 23-Aug-23 | Grant | 53,192 | -- | -- | 2660% 2.0K to 55.19K | |
25-Aug-23 4:15 PM View: | Malenfant Gavin T. Chief Operating Officer | Promis Neurosciences Inc. (PMN) | 23-Aug-23 | Grant | 2,660 | -- | -- | 100% 0 to 2.66K | |
25-Aug-23 4:15 PM View: | Kirwin Patrick D. Director | Promis Neurosciences Inc. (PMN) | 23-Aug-23 | Grant | 11,000 | -- | -- | 14% 78.1K to 89.1K | |
25-Aug-23 4:15 PM View: | Cashman Neil Chief Scientific Officer Director | Promis Neurosciences Inc. (PMN) | 23-Aug-23 | Grant | 10,643 | -- | -- | 10% 104.28K to 114.92K | |
19-Dec-22 4:50 PM View: | Williams Eugene Director | Promis Neurosciences Inc. (PMN) | 16-Dec-22 | Private Purchase | 2,000 | $4.64 | $9,290.00 | 1% 157.93K to 159.93K | |
15-Dec-22 6:05 PM View: | Kirwin Patrick D. Director | Promis Neurosciences Inc. (PMN) | 15-Dec-22 | Purchase | 2,000 | $4.51 | $9,020.00 | 3% 76.1K to 78.1K | |
16-Dec-22 3:30 PM View: | Farfel Gail M Chief Executive Officer | Promis Neurosciences Inc. (PMN) | 14-Dec-22 | Private Purchase | 1,000 | $4.94 | $4,940.00 | 100% 1.0K to 2.0K | |
15-Dec-22 6:05 PM View: | Kirwin Patrick D. Director | Promis Neurosciences Inc. (PMN) | 13-Dec-22 | Private Purchase | 1,000 | $4.87 | $4,870.00 | 1% 75.1K to 76.1K | |
13-Dec-22 11:59 AM View: | Williams Eugene Director | Promis Neurosciences Inc. (PMN) | 12-Dec-22 | Private Purchase | 1,000 | $5.07 | $5,075.00 | < 1% 156.93K to 157.93K | |
13-Dec-22 11:43 AM View: | Kirwin Patrick D. Director | Promis Neurosciences Inc. (PMN) | 09-Dec-22 | Private Purchase | 1,000 | $4.98 | $4,980.00 | 1% 74.1K to 75.1K | |
08-Dec-22 5:36 PM View: | Williams Eugene Director | Promis Neurosciences Inc. (PMN) | 07-Dec-22 | Market Purchase | 1,000 | $5.49 | $5,486.40 | < 1% 155.93K to 156.93K | 7% |
08-Dec-22 5:24 PM View: | Farfel Gail M Chief Executive Officer | Promis Neurosciences Inc. (PMN) | 06-Dec-22 | Market Purchase | 1,000 | $5.70 | $5,700.00 | 100% 0 to 1.0K | 3% |
06-Dec-22 4:32 PM View: | Williams Eugene Director | Promis Neurosciences Inc. (PMN) | 02-Dec-22 | Market Purchase | 1,000 | $5.98 | $5,980.00 | < 1% 154.93K to 155.93K | (2%) |
18-Aug-22 4:05 PM View: | Kirwin Patrick D. Director | Promis Neurosciences Inc. (PMN) | 17-Aug-22 | Market Purchase | 4,000 | $5.92 | $23,680.00 | 6% 68.43K to 72.43K | (< 1%) |
12-Jul-22 12:57 PM View: | Williams Eugene Chairman and CEO Director | Promis Neurosciences Inc. (PMN) | 11-Jul-22 | Purchase | 1,000 | $9.80 | $9,800.00 | < 1% 153.93K to 154.93K |